October 20, 2014 10:19 PM ET


Company Overview of SpringLeaf Therapeutics, Inc.

Executive Profile

Pieter Muntendam M.D.

Chief Executive Officer, President and Director, SpringLeaf Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships


Dr. Pieter Muntendam, M.D. serves as the Chief Executive Officer and President of scPharmaceuticals LLC. Dr. Muntendam founded scPharmaceuticals in February 2013. He has been the Chief Executive Officer and President of SpringLeaf Therapeutics, Inc. since September 19, 2012. He served as the Chief Medical Officer and Executive Vice President of BG Medicine, Inc. from January 2012 to June 11, 2012. He served as the President of BG Medicine, Inc. from November 2004 to ...

Corporate Headquarters

8 Saint Mary's Street
Boston, Massachusetts 02215

United States

Phone: 617-358-4927
Fax: 617-358-5657

Board Members Memberships

Former Chief Medical Officer, Executive Vice President and Member of LTBS Board
Chief Executive Officer, President and Director


Universiteit Leiden

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SpringLeaf Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.